Published: 2023 May 08

Pruritus Therapeutics Market Demand, Trends, Outlook and Market Forecast 2023-2030

SKU : PH2160
180 pages
Report Summary
Table of Contents
List of Tables & Figures

Pruritus Therapeutics Market is segmented By Product Type (Antihistamines, Corticosteroids, Counterirritants, Local Anesthetics, Calcineurin Inhibitors, Immunosuppressant, Others), By Disease Type (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Others), By End-User (Hospitals, Clinics, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030


Pruritus Therapeutics Market Overview

Pruritus Therapeutics Market is estimated to reach at a CAGR of 6.1% during the forecast period (2023-2030).  Pruritus, or itch, is commonly associated with primary skin disorders such as atopic dermatitis, urticaria, psoriasis, Masto cytosis, and dermatitis herpetiformis, among others. A typical itching generally forms the diagnosis of a major dermatologic disorder. Several skin diseases related to pruritus, such as renal pruritus, hematologic pruritus, cholestatic pruritus, idiopathic generalized pruritus, pruritus related to malignancy and endocrine pruritus. Increased ions such as calcium, phosphate, and magnesium are found in pruritic patients' skin. Severe pruritus leads to scratching that causes secondary skin problems such as eczematisation, dryness, infection, excoriation, Contact allergy, and lichenification.


Pruritus Therapeutics Market Summary and Scope



Market CAGR


Segments Covered

By Disease Type, By Drug Class, By Route of Administration, By Distribution Channel, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America


As per DataM Intelligence, Pruritus Therapeutics Market study analysis offers an in-depth outlook on the market containing quantitative and qualitative data. It gives an outlook and forecast of the global market based on market segmentation. It also provides global Pruritus Therapeutics Market size, and growth, along with the latest trends, opportunities, and forecast till 2029 for the global market with esteem to major countries such as the United States, Canada, Brazil, Germany, Italy, Spain, United Kingdom, Russia, European countries, United Arab Emirates, Saudi Arabia, South Africa, Japan, China, India, South Korea, Australia, and rest of the countries over the globe.

Among all regions, the North American region is expected to hold the largest share of the global market over the forecast period. Pruritus Therapeutics Market in the United States and Canada produces the utmost share. Whereas the European Pruritus Therapeutics Market is projected to continue its presence globally during the period of 2023- 2030.

Pruritus Therapeutics Market Dynamics and Trends

The global pruritus therapeutics market is growing due to several factors, such as the increasing incidence of dermatological disorders influencing the occurrence of pruritus and the growing demand for proper diagnostics and therapeutics to treat such medical conditions.

The development of new therapeutics for pruritus is forcing global market growth.

The development of new targeted therapies for different pruritus is driving the growth of the global pruritus therapeutics market. For instance, the development of Duplimab, which is a monoclonal antibody that specifically targets interleukin-4 receptors that are involved in the progression of the inflammatory response with these other novel therapeutics, for example, Crisaborole 2% ointment and others are in the pipeline of major key market players for topical medication including the Janus kinase inhibitors. Furthermore, the approval of these newly developed therapeutics by different regulatory bodies propels the market towards growth. For instance, in June 2022, Dupixent (Duplimab), developed by Sanofi, is the first biologics medicine validated by the United States Food and Drug Administration to treat moderate to severe dermatitis in children aged 6 months to 5 years. These market events and the development of new therapeutics are fueling the market growth globally.

The lack of awareness and incidences of drug side effects will become a hurdle in the pruritus therapeutics market growth.

However, the lack of awareness towards therapeutics for pruritus and the associated side effects associated with pruritus therapeutics hinder the market's growth. 

Industry analysis

The pruritus therapeutics market report will provide an in-depth analysis of the market based on various industry factors such as porter`s five forces, research and developments, epidemiology, regulatory analysis, pricing analysis and pipeline analysis, Etc.

COVID-19 Impact Analysis on Pruritus Therapeutics Market

The American Contact Dermatitis Society informed that the covid-19 pandemic had increased the number of contact dermatitis cases. Amidst covid-19, the CDC recommended repetitive hand hygiene with soaps, detergents, and hand sanitization through alcohol-containing hand sanitizers, which lead to the integrity and integrity function alteration in the skin barrier, raising the risk of dermatitis. Also, during the covid-19 outbreak, healthcare professionals were suggested to employ personal protective kits, which have caused a rise in the number of healthcare professionals experiencing contact dermatitis, positively impacting the pruritus therapeutics market.

Pruritus Therapeutics Market Segmentation Analysis

The corticosteroids will dominate the pruritus therapeutics market during the forecast period (2023-2030).

The corticosteroids segment accounted for the highest market share in 2021 and is expected to dominate the Pruritus therapeutics market during the forecast period (2022-2029) since corticosteroids are widely used as the first line of treatment for acute pruritus associated with moderate to severe inflammatory skin diseases, such as AD, allergic contact dermatitis, psoriasis and lichen planus. Corticosteroids are activated glucocorticoid receptors that inhibit cytokine activation, thereby decreasing local inflammation and indirectly controlling pruritus. More than 30 different topical steroid formulations are available in the United States, and these are prepared on different bases (e.g., solution, lotion, cream or ointment). Topical corticosteroids range in potency from low (Class VII) to high or ultra-potent (Class I). It is generally accepted that the clinical efficacy to treat inflammation, and indirectly pruritus, correlates with steroid potency. 

Pruritus Therapeutics Market Geographical Share

North America is subjugating the pruritus therapeutics market.

North America dominated the pruritus therapeutics market in 2021. It is estimated that North America will command the global pruritus therapeutics market during the forecast period (2022-2029) since most key market players are headquartered in North America and are involved in developing new drug therapies such as biologics. Examples are Bausch Health, Astellas Pharma U.S.Inc., Pfizer Inc., Mylan, Bayer AG, Allergen, Eli Lilly, and many more. Also, owing to the health care sector developments, organizations and societies are actively looking out for pruritus and government initiatives for spreading awareness about pruritus. For instance, founded in 1989, the American Contact Dermatitis Society is focused on pruritus with over 2,500 healthcare professionals in the field of pruritus and related skin inflammatory diseases. Also, the North American Contact Dermatitis Group is helping thousands of people make informed, evidence-based skin care decisions. These facts show that the North American region will dominate the pruritus therapeutics market over the forecast period.

Pruritus Therapeutics Companies and Competitive Landscape 

The pruritus therapeutics market is competitive, with few major players competing to gain market share. Some major players in the global pruritus therapeutics market include Allergan Inc., Amgen Inc., Astellas Pharma Inc., CARA Therapeutics, Novartis AG, Teva Pharmaceutical Industries Ltd, Pfizer, Sanofi, GlaxoSmithKline, Merck, among others. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations contributing to the global Pruritus Therapeutics market's growth. For instance, in January 2022, Pfizer acquired U.S.FDA approval for its Cibinqo (Adrocitinib), an oral once-a-day Janus kinase inhibitor for treating adults suffering from dermatitis. Also, in April 2022, Leo Pharma presented its interim long-term efficacy data for Adbry (Tralokinumab-ldrm). Such incidences create a competitive environment in the Pruritus Therapeutics market.

Leo Pharma


Leo Pharma is a leading company in the dermatology market, founded in 1908 and headquartered in Denmark. It is primarily focused on research and development to advance the science of dermatology.

Product Portfolio

Leo Pharma’s dermatological product portfolio has Adtralza, Dovobet, Dovonex, Enstilar, Finacea, Kyntheum, Protopic, Skinoren, Fucidin, and Fucibet.

The global pruritus therapeutics market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) page.

Buy this report
Single User
Multiple User
Enterprise User
Proceed to Buy
What is the Projected CAGR value of the Pruritus Therapeutics Market?
Pruritus Therapeutics Market is expected to grow at a CAGR of 6.1% during the forecasting period 2023-2030.
Which is the fastest growing region in the Pruritus Therapeutics Market?
Among all regions, Asia Pacific is the fastest growing market share during the forecast period.
Related Reports

Melanoma Therapeutics Market

Published: 2022 September 21
Starting from



Eczema Therapeutics Market Size, Share, Trends, Outlook, Growth Opportunities, and Forecast 2023 - 2030

Published: 2023 May 12
Starting from



Glaucoma Therapeutic Market Size, Competitive Landscape and Market Forecast - 2030

Published: 2023 April 24
Starting from



Leukemia Therapeutics Market Size, Competitive Landscape and Market Forecast - 2029

Published: 2022 June 23
Starting from



Xerostomia Therapeutics Market Volume, Demand, Trends, Volume, Size and Market Forecast 2023-2030

Published: 2023 May 08
Starting from



Influenza Therapeutics Market Size, Competitive Landscape and Market Forecast - 2029

Published: 2022 June 02
Starting from